Search research articles
Contact Us
Filters
Showing results (51-60 of 439) with videos related to
Page
of 44
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 30, 2013
Molecular profiling and the reclassification of cancer: divide and conquer
Javier Munoz, Charles Swanton, Razelle Kurzrock
Biochemical Pharmacology
|
December 24, 2011
Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics
Alvin J X Lee, Charles Swanton
Cell
|
December 7, 2015
SnapShot: Renal Cell Carcinoma
Samra Turajlic, James Larkin, Charles Swanton
British Journal of Cancer
|
February 24, 2021
Understanding the impact of immune-mediated selection on lung cancer evolution
Rachel Rosenthal, Charles Swanton, Nicholas McGranahan
Expert Review of Anticancer Therapy
|
April 21, 2011
Optimizing treatment of metastatic renal cell carcinoma by changing mechanism of action
James Larkin, Charles Swanton, Lisa Pickering
The EPMA Journal
|
June 29, 2012
Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneity
Rosalie Fisher, James Larkin, Charles Swanton
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2006
Her2-targeted therapies in non-small cell lung cancer
Charles Swanton, Andy Futreal, Tim Eisen
Biochimica Et Biophysica Acta
|
April 2, 2015
Inferring mutational timing and reconstructing tumour evolutionary histories
Samra Turajlic, Nicholas McGranahan, Charles Swanton
Seminars in Cancer Biology
|
February 25, 2021
Impact of cancer evolution on immune surveillance and checkpoint inhibitor response
Yin Wu, Dhruva Biswas, Charles Swanton
The EMBO Journal
|
August 30, 2021
Cancer evolution: Darwin and beyond
Roberto Vendramin, Kevin Litchfield, Charles Swanton
Page
of 44
Search research articles
Search
Showing results (51-60 of 439) with videos related to
Sort By:
Page
of 44
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 30, 2013
Molecular profiling and the reclassification of cancer: divide and conquer
Javier Munoz, Charles Swanton, Razelle Kurzrock
Biochemical Pharmacology
|
December 24, 2011
Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics
Alvin J X Lee, Charles Swanton
Cell
|
December 7, 2015
SnapShot: Renal Cell Carcinoma
Samra Turajlic, James Larkin, Charles Swanton
British Journal of Cancer
|
February 24, 2021
Understanding the impact of immune-mediated selection on lung cancer evolution
Rachel Rosenthal, Charles Swanton, Nicholas McGranahan
Expert Review of Anticancer Therapy
|
April 21, 2011
Optimizing treatment of metastatic renal cell carcinoma by changing mechanism of action
James Larkin, Charles Swanton, Lisa Pickering
The EPMA Journal
|
June 29, 2012
Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneity
Rosalie Fisher, James Larkin, Charles Swanton
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2006
Her2-targeted therapies in non-small cell lung cancer
Charles Swanton, Andy Futreal, Tim Eisen
Biochimica Et Biophysica Acta
|
April 2, 2015
Inferring mutational timing and reconstructing tumour evolutionary histories
Samra Turajlic, Nicholas McGranahan, Charles Swanton
Seminars in Cancer Biology
|
February 25, 2021
Impact of cancer evolution on immune surveillance and checkpoint inhibitor response
Yin Wu, Dhruva Biswas, Charles Swanton
The EMBO Journal
|
August 30, 2021
Cancer evolution: Darwin and beyond
Roberto Vendramin, Kevin Litchfield, Charles Swanton
Page
of 44